A year after the US Food and Drug Administration (FDA) opened the door to clinical use of lysergic acid diethylamide (LSD), US-based MindMed has launched phase 3 trials in the United States and Europe ...
LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...
Recent analysis of federal health data suggests that the recreational use of LSD is associated with a lower likelihood of alcohol use disorder. This finding stands in contrast to the use of other ...
Lifetime LSD use is associated with a higher likelihood of severe psychological distress after losing one's job, according to a new study. Lifetime LSD use is associated with a higher likelihood of ...
LSD was first synthesized by Swiss chemist Albert Hofmann in 1938. He discovered its powerful psychoactive effects in 1943 after accidentally ingesting a small amount and experiencing vivid ...
Psychedelic drugs, such as lysergic acid diethylamide (LSD), can increase neuronal growth, which can have therapeutic effects for conditions such as schizophrenia. However, such drugs can induce ...
In 1943, a chemist in Switzerland synthesized a drug that alters consciousness. His discovery changed the study of medicine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results